blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2346804

EP2346804 - COMPOSITION COMPRISING CB RECEPTOR AGONISTS AND USES THEREOF [Right-click to bookmark this link]
Former [2011/30]COMPOSITIONS COMPRISING CB RECEPTOR AGONISTS, USES THEREOF AND METHODS FOR THEIR PREPARATION
[2016/43]
StatusNo opposition filed within time limit
Status updated on  12.01.2018
Database last updated on 11.05.2024
FormerThe patent has been granted
Status updated on  03.02.2017
FormerGrant of patent is intended
Status updated on  31.01.2017
Most recent event   Tooltip06.03.2020Lapse of the patent in a contracting state
New state(s): TR		published on 08.04.2020  [2020/15]
Applicant(s)For all designated states
Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd.
Hi Tech Park Edmond Safra Campus Givat Ram
Jerusalem 91390 / IL
[2011/30]
Inventor(s)01 / BAB, Itai
26 Hateena Street
99797 Carmei Yossef / IL
02 / MECHOULAM, Raphael
12 Tchernichovsky Street
92581 Jerusalem / IL
03 / BREUER, Aviva
18 Nave Shaanan St.
93707 Jerusalem / IL
04 / MUSSAI, Naama
7/14 Hakblan st
93874 Jerusalem / IL
 [2011/30]
Representative(s)AMMANN PATENTANWÄLTE AG
Schwarztorstrasse 31
3001 Bern / CH
[N/P]
Former [2017/10]AMMANN PATENTANWÄLTE AG BERN
Schwarztorstrasse 31
3001 Bern / CH
Former [2011/30]AMMANN PATENTANWÄLTE AG BERN
Schwarztorstrasse 31
3001 Bern / CH
Application number, filing date09760006.811.10.2009
[2011/30]
WO2009IL00964
Priority number, dateUS20080103054P06.10.2008         Original published format: US 103054 P
US20090165011P31.03.2009         Original published format: US 165011 P
[2011/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010041253
Date:15.04.2010
Language:EN
[2010/15]
Type: A1 Application with search report 
No.:EP2346804
Date:27.07.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 15.04.2010 takes the place of the publication of the European patent application.
[2011/30]
Type: B1 Patent specification 
No.:EP2346804
Date:08.03.2017
Language:EN
[2017/10]
Search report(s)International search report - published on:EP15.04.2010
ClassificationIPC:C07C67/14, C07C67/29, C07C67/293, C07C41/26, C07C43/23
[2016/43]
CPC:
C07C43/23 (EP,US); A61P1/16 (EP); A61P19/02 (EP);
A61P19/10 (EP); A61P25/04 (EP); A61P29/00 (EP);
A61P3/04 (EP); A61P3/10 (EP); A61P35/00 (EP);
A61P37/08 (EP); A61P9/00 (EP); C07C41/26 (EP,US);
C07C67/14 (EP,US); C07C67/29 (EP,US); C07C67/293 (EP,US);
C07B2200/07 (EP,US); C07C2601/16 (EP,US); C07C2602/42 (EP,US) (-)
C-Set:
C07C41/26, C07C43/23 (EP,US);
C07C67/14, C07C69/14 (US);
C07C67/14, C07C69/24 (EP,US);
C07C67/293, C07C69/24 (US,EP);
C07C67/29, C07C69/24 (US,EP)
(-)
Former IPC [2011/30]C07C39/17, C07C39/23, C07C43/178, C07C69/753, A61K31/09
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2017/10]
Former [2011/30]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:CB-REZEPTOR-AGOR-AGONISTEN ENTHALTENDE ZUSAMMENSETZUNGEN UND ANWENDUNGEN DAVON[2016/43]
English:COMPOSITION COMPRISING CB RECEPTOR AGONISTS AND USES THEREOF[2016/43]
French:COMPOSITIONS COMPRENANT DES AGONISTES DU RECEPTEUR CB ET LEURS UTILISATIONS[2016/43]
Former [2011/30]CB-REZEPTOR-AGOR-AGONISTEN ENTHALTENDE ZUSAMMENSETZUNGEN, ANWENDUNGEN DAVON UND VERFAHREN ZU IHRER HERSTELLUNG
Former [2011/30]COMPOSITIONS COMPRISING CB RECEPTOR AGONISTS, USES THEREOF AND METHODS FOR THEIR PREPARATION
Former [2011/30]COMPOSITIONS COMPRENANT DES AGONISTES DU RECEPTEUR CB, LEURS UTILISATIONS ET LEURS PROCEDES DE PREPARATION
Entry into regional phase14.04.2011National basic fee paid 
14.04.2011Designation fee(s) paid 
14.04.2011Examination fee paid 
Examination procedure14.04.2011Amendment by applicant (claims and/or description)
14.04.2011Examination requested  [2011/30]
03.06.2013Despatch of a communication from the examining division (Time limit: M06)
13.01.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
18.03.2014Reply to a communication from the examining division
20.09.2016Cancellation of oral proceeding that was planned for 13.10.2016
13.10.2016Date of oral proceedings (cancelled)
21.10.2016Communication of intention to grant the patent
24.01.2017Fee for grant paid
24.01.2017Fee for publishing/printing paid
24.01.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  03.06.2013
Opposition(s)11.12.2017No opposition filed within time limit [2018/07]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
18.03.2014Request for further processing filed
18.03.2014Full payment received (date of receipt of payment)
Request granted
27.03.2014Decision despatched
Fees paidRenewal fee
14.10.2011Renewal fee patent year 03
23.10.2012Renewal fee patent year 04
24.10.2013Renewal fee patent year 05
23.10.2014Renewal fee patent year 06
26.10.2015Renewal fee patent year 07
21.10.2016Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU11.10.2009
AT08.03.2017
CY08.03.2017
CZ08.03.2017
DK08.03.2017
EE08.03.2017
ES08.03.2017
FI08.03.2017
HR08.03.2017
IT08.03.2017
LT08.03.2017
LV08.03.2017
MC08.03.2017
MK08.03.2017
NL08.03.2017
PL08.03.2017
RO08.03.2017
SE08.03.2017
SI08.03.2017
SK08.03.2017
SM08.03.2017
TR08.03.2017
BG08.06.2017
NO08.06.2017
GR09.06.2017
IS08.07.2017
PT10.07.2017
IE11.10.2017
LU11.10.2017
MT11.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
[2020/15]
Former [2019/51]HU11.10.2009
AT08.03.2017
CY08.03.2017
CZ08.03.2017
DK08.03.2017
EE08.03.2017
ES08.03.2017
FI08.03.2017
HR08.03.2017
IT08.03.2017
LT08.03.2017
LV08.03.2017
MC08.03.2017
MK08.03.2017
NL08.03.2017
PL08.03.2017
RO08.03.2017
SE08.03.2017
SI08.03.2017
SK08.03.2017
SM08.03.2017
BG08.06.2017
NO08.06.2017
GR09.06.2017
IS08.07.2017
PT10.07.2017
IE11.10.2017
LU11.10.2017
MT11.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
Former [2019/46]HU11.10.2009
AT08.03.2017
CY08.03.2017
CZ08.03.2017
DK08.03.2017
EE08.03.2017
ES08.03.2017
FI08.03.2017
HR08.03.2017
IT08.03.2017
LT08.03.2017
LV08.03.2017
MC08.03.2017
NL08.03.2017
PL08.03.2017
RO08.03.2017
SE08.03.2017
SI08.03.2017
SK08.03.2017
SM08.03.2017
BG08.06.2017
NO08.06.2017
GR09.06.2017
IS08.07.2017
PT10.07.2017
IE11.10.2017
LU11.10.2017
MT11.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
Former [2019/31]HU11.10.2009
AT08.03.2017
CZ08.03.2017
DK08.03.2017
EE08.03.2017
ES08.03.2017
FI08.03.2017
HR08.03.2017
IT08.03.2017
LT08.03.2017
LV08.03.2017
MC08.03.2017
NL08.03.2017
PL08.03.2017
RO08.03.2017
SE08.03.2017
SI08.03.2017
SK08.03.2017
SM08.03.2017
BG08.06.2017
NO08.06.2017
GR09.06.2017
IS08.07.2017
PT10.07.2017
IE11.10.2017
LU11.10.2017
MT11.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
Former [2018/45]AT08.03.2017
CZ08.03.2017
DK08.03.2017
EE08.03.2017
ES08.03.2017
FI08.03.2017
HR08.03.2017
IT08.03.2017
LT08.03.2017
LV08.03.2017
MC08.03.2017
NL08.03.2017
PL08.03.2017
RO08.03.2017
SE08.03.2017
SI08.03.2017
SK08.03.2017
SM08.03.2017
BG08.06.2017
NO08.06.2017
GR09.06.2017
IS08.07.2017
PT10.07.2017
IE11.10.2017
LU11.10.2017
MT11.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
Former [2018/43]AT08.03.2017
CZ08.03.2017
DK08.03.2017
EE08.03.2017
ES08.03.2017
FI08.03.2017
HR08.03.2017
IT08.03.2017
LT08.03.2017
LV08.03.2017
MC08.03.2017
NL08.03.2017
PL08.03.2017
RO08.03.2017
SE08.03.2017
SI08.03.2017
SK08.03.2017
SM08.03.2017
BG08.06.2017
NO08.06.2017
GR09.06.2017
IS08.07.2017
PT10.07.2017
LU11.10.2017
MT11.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
Former [2018/36]AT08.03.2017
CZ08.03.2017
DK08.03.2017
EE08.03.2017
ES08.03.2017
FI08.03.2017
HR08.03.2017
IT08.03.2017
LT08.03.2017
LV08.03.2017
MC08.03.2017
NL08.03.2017
PL08.03.2017
RO08.03.2017
SE08.03.2017
SI08.03.2017
SK08.03.2017
SM08.03.2017
BG08.06.2017
NO08.06.2017
GR09.06.2017
IS08.07.2017
PT10.07.2017
LU11.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
Former [2018/35]AT08.03.2017
CZ08.03.2017
DK08.03.2017
EE08.03.2017
ES08.03.2017
FI08.03.2017
HR08.03.2017
IT08.03.2017
LT08.03.2017
LV08.03.2017
MC08.03.2017
NL08.03.2017
PL08.03.2017
RO08.03.2017
SE08.03.2017
SI08.03.2017
SK08.03.2017
SM08.03.2017
BG08.06.2017
NO08.06.2017
GR09.06.2017
IS08.07.2017
PT10.07.2017
LU11.10.2017
CH31.10.2017
LI31.10.2017
Former [2018/29]AT08.03.2017
CZ08.03.2017
DK08.03.2017
EE08.03.2017
ES08.03.2017
FI08.03.2017
HR08.03.2017
IT08.03.2017
LT08.03.2017
LV08.03.2017
MC08.03.2017
NL08.03.2017
PL08.03.2017
RO08.03.2017
SE08.03.2017
SI08.03.2017
SK08.03.2017
SM08.03.2017
BG08.06.2017
NO08.06.2017
GR09.06.2017
IS08.07.2017
PT10.07.2017
Former [2018/14]AT08.03.2017
CZ08.03.2017
DK08.03.2017
EE08.03.2017
ES08.03.2017
FI08.03.2017
HR08.03.2017
IT08.03.2017
LT08.03.2017
LV08.03.2017
NL08.03.2017
PL08.03.2017
RO08.03.2017
SE08.03.2017
SI08.03.2017
SK08.03.2017
SM08.03.2017
BG08.06.2017
NO08.06.2017
GR09.06.2017
IS08.07.2017
PT10.07.2017
Former [2018/09]AT08.03.2017
CZ08.03.2017
DK08.03.2017
EE08.03.2017
ES08.03.2017
FI08.03.2017
HR08.03.2017
IT08.03.2017
LT08.03.2017
LV08.03.2017
NL08.03.2017
PL08.03.2017
RO08.03.2017
SE08.03.2017
SK08.03.2017
SM08.03.2017
BG08.06.2017
NO08.06.2017
GR09.06.2017
IS08.07.2017
PT10.07.2017
Former [2017/51]AT08.03.2017
CZ08.03.2017
EE08.03.2017
ES08.03.2017
FI08.03.2017
HR08.03.2017
IT08.03.2017
LT08.03.2017
LV08.03.2017
NL08.03.2017
PL08.03.2017
RO08.03.2017
SE08.03.2017
SK08.03.2017
SM08.03.2017
BG08.06.2017
NO08.06.2017
GR09.06.2017
IS08.07.2017
PT10.07.2017
Former [2017/50]AT08.03.2017
CZ08.03.2017
EE08.03.2017
ES08.03.2017
FI08.03.2017
HR08.03.2017
IT08.03.2017
LT08.03.2017
LV08.03.2017
NL08.03.2017
PL08.03.2017
RO08.03.2017
SE08.03.2017
SK08.03.2017
BG08.06.2017
NO08.06.2017
GR09.06.2017
IS08.07.2017
Former [2017/49]AT08.03.2017
CZ08.03.2017
EE08.03.2017
ES08.03.2017
FI08.03.2017
HR08.03.2017
IT08.03.2017
LT08.03.2017
LV08.03.2017
NL08.03.2017
RO08.03.2017
SE08.03.2017
SK08.03.2017
BG08.06.2017
NO08.06.2017
GR09.06.2017
IS08.07.2017
Former [2017/48]CZ08.03.2017
ES08.03.2017
FI08.03.2017
HR08.03.2017
LT08.03.2017
LV08.03.2017
NL08.03.2017
SE08.03.2017
BG08.06.2017
NO08.06.2017
GR09.06.2017
Former [2017/41]ES08.03.2017
FI08.03.2017
HR08.03.2017
LT08.03.2017
LV08.03.2017
NL08.03.2017
SE08.03.2017
BG08.06.2017
NO08.06.2017
GR09.06.2017
Cited inInternational search[X]US4282248  (MECHOULAM RAPHAEL, et al) [X] 1-37 * the whole document *;
 [X]WO03005960  (UNIV CONNECTICUT [US], et al) [X] 1-37 * page 2, lines 19-26; page 3, compound I; page 16, compounds I - III; page 29, Scheme 3; page 31, Scheme 4; claims *;
 [X]US2007248702  (FERNANDEZ-RUIZ JAVIER [ES]) [X] 1-37* [0018]; [0078-0079]; claims *;
 [XA]  - LEVIN S ET AL, "STRUCTURAL FEATURES AFFECTING CHIRAL RESOLUTION OF CANNABIMIMETIC ENANTIOMERS BY AMYLOSE 3,5-DIMETHYLPHENYLCARBAMATE CHIRAL STATIONARY PHASE", CHIRALITY, WILEY-LISS, NEW YORK, US, (19950101), vol. 7, no. 3, ISSN 0899-0042, pages 140 - 146, XP009007782 [X] 1-22,37 * page 141, compound "HU-256"; page 145, Fig. 6 and Fig. 7 * [A] 23-36

DOI:   http://dx.doi.org/10.1002/chir.530070306
 [XA]  - MECHOULAM R ET AL, "Cannabimimetic activity of novel enantiomeric, benzofuran cannabinoids", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, US, (19900101), vol. 33, no. 3, ISSN 0022-2623, pages 1037 - 1043, XP002414722 [X] 1-22,37 * page 1037, Scheme 1, compound 5 * [A] 23-36

DOI:   http://dx.doi.org/10.1021/jm00165a024
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.